Research letter
Response of alopecia areata of the beard to oral tofacitinib

https://doi.org/10.1016/j.jaad.2019.10.058Get rights and content

First page preview

First page preview
Click to open first page preview

References (5)

  • J. Cervantes et al.

    Alopecia areata of the beard: a review of the literature

    Am J Clin Dermatol

    (2017)
  • Y. Ramot et al.

    Complete regrowth of beard hair with ruxolitinib in an alopecia universalis patient

    Skin Appendage Disord

    (2018)
There are more references available in the full text version of this article.

Cited by (10)

View all citing articles on Scopus

Funding sources: Dr Bhoyrul was supported by The Geoffrey Dowling Fellowship from the British Association of Dermatologists.

Disclosure: Dr Sinclair has professional services associated with Leo Pharma, Amgen, Novartis, Merck & Co, Celgene, Coherus BioSciences, Janssen, Regeneron, MedImmune, GlaxoSmithKline, Cutanea, Samson Clinical, Boehringer Ingelheim, Pfizer, MSD, Oncobiologics, Roche, Eli Lilly, Bayer, and Sun Pharma. Ms Kerkemeyer, Mr John, and Mr Bhoyrul have no conflicts of interest to declare.

IRB approval status: Not applicable.

View full text